HopeStageGet research updates
HopeStage
hi@hopestage.com

Built by people with lived experience, between Sydney and Paris.

Back to overview

Schizophrenia studies

Topics
More filters

Schizophrenia

Schizophrenia can affect how a person perceives reality, thinks and feels, sometimes involving hearing voices or holding unusual beliefs.

4505studies shown
Showing 1,933-1,944 of 4,505
Drug study icon
Recruitment unclearEUCTR 2009-018038-12

A 26-week, multi-center, open-label, flexible dose, long-term safety trial of asenapine in adolescent subjects with schizophrenia

Current recruitment status is unconfirmed.

This older record does not confirm current recruitment. No matching public CTIS record was confirmed using this identifier. Ask the research team for an up-to-date source.

In Romania
SchizophreniaHistorical research record
Countries
Romania
Sponsor
Schering-Plough Research Institute, a Division of Schering Corporation
View study
Drug study icon
Recruitment unclearEUCTR 2004-002591-42

A pharmacoeconomic study conducted in parallel with clinical trial 10200, a 24-week double-blind, risperidone-referenced, flexible dose, parallel-group extension study of bifeprunox in patients wit...

Current recruitment status is unconfirmed.

This older record does not confirm current recruitment. No matching public CTIS record was confirmed using this identifier. Ask the research team for an up-to-date source.

In Spain
SchizophreniaHistorical research record
Countries
Spain
Sponsor
H.Lundbeck A/S
View study
Drug study icon
Recruitment unclearEUCTR 2017-001739-38

A Phase 2 Randomized, Double-Blind, Placebo-Controlled, Cross-Over Study to Evaluate Pharmacodynamic Effects, Safety, Tolerability, and pharmacokinetics of Multiple Oral Doses of TAK-831 in Adult...

Current recruitment status is unconfirmed.

This older record does not confirm current recruitment. No matching public CTIS record was confirmed using this identifier. Ask the research team for an up-to-date source.

In United Kingdom
SchizophreniaHistorical research record
Countries
United Kingdom
Sponsor
Takeda Development Centre Europe Ltd.
View study
Drug study icon
Recruitment unclearEUCTR 2018-002740-82

A phase II randomized, double-blinded, placebo-controlled parallel group trial to examine the efficacy and safety of BI 425809 once daily with adjunctive Computerized Cognitive Training over 12 wee...

Current recruitment status is unconfirmed.

This older record does not confirm current recruitment. No matching public CTIS record was confirmed using this identifier. Ask the research team for an up-to-date source.

In United Kingdom
SchizophreniaHistorical research record
Countries
United Kingdom
Sponsor
Boehringer Ingelheim Limited
View study
Drug study icon
Recruitment unclearEUCTR 2020-006062-36

A PHASE II/III, PROSPECTIVE, MULTI-CENTER, RANDOMIZED, 4-WEEK, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY, DESIGNED TO DETERMINE THE SAFETY, TOLERABILITY, EEG EFFECTS AND EFFICACY OF ORAL DOSES OF 30 M...

Current recruitment status is unconfirmed.

This older record does not confirm current recruitment. No matching public CTIS record was confirmed using this identifier. Ask the research team for an up-to-date source.

In Czech Republic
SchizophreniaHistorical research record
Countries
Czechia, Estonia, Germany, + 6 others
Sponsor
Newron Pharmaceuticals S.p.A.
View study
Drug study icon
Recruitment unclearEUCTR 2009-017971-10

An 8-week, placebo-controlled, double-blind, randomized, fixed-dose efficacy and safety trial of asenapine in adolescent subjects with schizophrenia

Current recruitment status is unconfirmed.

This older record does not confirm current recruitment. No matching public CTIS record was confirmed using this identifier. Ask the research team for an up-to-date source.

In Romania
SchizophreniaHistorical research record
Countries
Romania
Sponsor
Schering-Plough Research Institute, a Division of Schering Corporation
View study
Drug study icon
Recruitment unclearEUCTR 2017-001168-39

An Adaptive, Phase IIb/III, Double-Blind, Randomized, Placebo- Controlled, Multi-Center Study of the Safety and Efficacy of NaBen® (sodium benzoate), a D-Amino Acid Oxidase Inhibitor, as an Add-on ...

Current recruitment status is unconfirmed.

This older record does not confirm current recruitment. No matching public CTIS record was confirmed using this identifier. Ask the research team for an up-to-date source.

In Poland
SchizophreniaHistorical research record
Countries
United Kingdom, Poland
Sponsor
SyneuRx International (Taiwan) Corp
View study
Drug study icon
Recruitment unclearEUCTR 2017-001169-26

An Adaptive, Phase IIb/III, Multi-center, Prospective, Randomized, Double-Blind Placebo-controlled Study of the Safety and Efficacy of NaBen® (sodium benzoate), a D-Amino Acid Oxidase Inhibitor, as...

Current recruitment status is unconfirmed.

This older record does not confirm current recruitment. No matching public CTIS record was confirmed using this identifier. Ask the research team for an up-to-date source.

In Poland
SchizophreniaHistorical research record
Countries
United Kingdom, Poland
Sponsor
SyneuRx International (Taiwan) Corp
View study
Drug study icon
Recruitment unclearEUCTR 2013-001315-71

Dopaminergic genotype of schizophrenic patients and the benefit of adjunctive aripiprazole to risperidone treatment. The effect on hormonal and metabolic measures

Current recruitment status is unconfirmed.

This older record does not confirm current recruitment. No matching public CTIS record was confirmed using this identifier. Ask the research team for an up-to-date source.

In Spain
SchizophreniaHistorical research record
Countries
Spain
Sponsor
Mercedes Zumarraga Ortiz
View study
Drug study icon
Recruitment unclearEUCTR 2012-005435-87

EFFECT OF ADJUVANT TREATMENT WITH N - ACETYLCYSTEINE DURING 48 WEEKS ON THE LOSS OF GREY SUBSTANCE AND OXIDATIVE METABOLISM IN PATIENTS WITH EARLY ONSET PSYCHOTIC EPISODES: BLIND, PLACEBO-CONTROLLE...

Current recruitment status is unconfirmed.

This older record does not confirm current recruitment. No matching public CTIS record was confirmed using this identifier. Ask the research team for an up-to-date source.

In Spain
SchizophreniaHistorical research record
Countries
Spain
Sponsor
Fundación para la Investigación Biomédica Hospital Gregorio Marañón
View study
Drug study icon
Recruitment unclearEUCTR 2017-004834-26

Influence of dose interval on the pharmacokinetics of both unbound and total fractions of clozapine and norclozapine in psychiatric patients in the Netherlands

Current recruitment status is unconfirmed.

This older record does not confirm current recruitment. No matching public CTIS record was confirmed using this identifier. Ask the research team for an up-to-date source.

In Netherlands
SchizophreniaHistorical research record
Countries
Netherlands
Sponsor
Albert Schweitzer hospital
View study

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.